Ten Hove M, Smyris A, Booijink R, Wachsmuth L, Hansen U, Alic L
Bioact Mater. 2024; 39:406-426.
PMID: 38855059
PMC: 11157122.
DOI: 10.1016/j.bioactmat.2024.05.034.
Yang H, Xie Y, Li T, Liu S, Zeng S, Wang B
Stem Cell Res Ther. 2021; 12(1):534.
PMID: 34627378
PMC: 8502355.
DOI: 10.1186/s13287-021-02599-w.
Li J, Kong L, Huang H, Luan S, Jin R, Wu F
FEBS Open Bio. 2020; 10(6):1044-1055.
PMID: 32237041
PMC: 7262943.
DOI: 10.1002/2211-5463.12850.
Zhao J, Jiang Y, Sun X, Liu X, Liu F, Song M
Biosci Rep. 2020; 40(3).
PMID: 32124915
PMC: 7069903.
DOI: 10.1042/BSR20193385.
Rao C, Ni Y, Zhao Y, Zhang Y, Zhou R, Liu C
Mol Med Rep. 2020; 21(2):667-674.
PMID: 31974596
PMC: 6947877.
DOI: 10.3892/mmr.2019.10881.
SUMOylation inhibitors synergize with FXR agonists in combating liver fibrosis.
Zhou J, Cui S, He Q, Guo Y, Pan X, Zhang P
Nat Commun. 2020; 11(1):240.
PMID: 31932588
PMC: 6957516.
DOI: 10.1038/s41467-019-14138-6.
p66Shc Contributes to Liver Fibrosis through the Regulation of Mitochondrial Reactive Oxygen Species.
Zhao Y, Wang Z, Feng D, Zhao H, Lin M, Hu Y
Theranostics. 2019; 9(5):1510-1522.
PMID: 30867846
PMC: 6401497.
DOI: 10.7150/thno.29620.
Autocrine CTHRC1 activates hepatic stellate cells and promotes liver fibrosis by activating TGF-β signaling.
Li J, Wang Y, Ma M, Jiang S, Zhang X, Zhang Y
EBioMedicine. 2019; 40:43-55.
PMID: 30639416
PMC: 6412555.
DOI: 10.1016/j.ebiom.2019.01.009.
Host Regulators of Liver Fibrosis During Human Schistosomiasis.
Kamdem S, Moyou-Somo R, Brombacher F, Nono J
Front Immunol. 2018; 9:2781.
PMID: 30546364
PMC: 6279936.
DOI: 10.3389/fimmu.2018.02781.
Hepatic Fibrosis in Dogs.
Eulenberg V, Lidbury J
J Vet Intern Med. 2017; 32(1):26-41.
PMID: 29194760
PMC: 5787209.
DOI: 10.1111/jvim.14891.
Effects of Enzymatically Depolymerized Low Molecular Weight Heparins on CCl-Induced Liver Fibrosis.
Yan Y, Guan C, Du S, Zhu W, Ji Y, Su N
Front Pharmacol. 2017; 8:514.
PMID: 28871223
PMC: 5566566.
DOI: 10.3389/fphar.2017.00514.
Wnt2b attenuates HSCs activation and liver fibrosis through negative regulating TLR4 signaling.
Yuan Y, Han Q, Li S, Tian Z, Zhang J
Sci Rep. 2017; 7(1):3952.
PMID: 28638086
PMC: 5479809.
DOI: 10.1038/s41598-017-04374-5.
Tyrosine kinase inhibitor BIBF1120 ameliorates inflammation, angiogenesis and fibrosis in CCl-induced liver fibrogenesis mouse model.
Ozturk Akcora B, Storm G, Prakash J, Bansal R
Sci Rep. 2017; 7:44545.
PMID: 28291245
PMC: 5349608.
DOI: 10.1038/srep44545.
Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets.
Zhang C, Yuan W, He P, Lei J, Wang C
World J Gastroenterol. 2017; 22(48):10512-10522.
PMID: 28082803
PMC: 5192262.
DOI: 10.3748/wjg.v22.i48.10512.
